FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891728466> ?p ?o ?g. }

• W2891728466 abstract "Gouty arthritis is characterized by an intense inflammatory response to monosodium urate crystals (MSU), which induces severe pain and reduction in the life quality of patients. Trans-Chalcone (1,3-diphenyl-2-propen-1-one) is a flavonoid precursor presenting biological activities such as anti-inflammatory and antioxidant proprieties. Thus, the aim of this work was to evaluate the protective effects of trans-Chalcone in experimental gout arthritis in mice. Mice were treated with trans-Chalcone (3, 10, or 30 mg/kg, per oral) or vehicle (Tween 80 20% plus saline) 30 min before intra-articular injection of MSU (100 μg/knee joint, intra-articular). We observed that trans-Chalcone inhibited MSU-induced mechanical hyperalgesia, edema, and leukocyte recruitment (total leukocytes, neutrophils, and mononuclear cells) in a dose-dependent manner. Trans-Chalcone also decreased inflammatory cell recruitment as observed in Hematoxylin and Eosin (HE) staining and the intensity of fluorescence of LysM-eGFP+ cells in the confocal microscopy. Trans-Chalcone reduced MSU-induced oxidative stress as observed by an increase in the antioxidant defense [Glutathione (GSH), Ferric Reducing (FRAP), and 2,2'-Azinobis-3-ethylbenzothiazoline 6-sulfonic acid (ABTS assays)] and reduction in reactive oxygen and nitrogen species production [superoxide anion (NBT assay) and nitrite (NO assay)]. Furthermore, it reduced in vivo MSU-induced interleukin-1β (IL-1β), Tumor necrosis factor-α (TNF-α), and IL-6 production, and increased Transforming growth factor-β (TGF-β) production. Importantly, trans-Chalcone reduced nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation and thereby the mRNA expression of the inflammasome components Nlrp3 (cryopyrin), Asc (apoptosis-associated speck-like protein containing a CARD), Pro-caspase-1 and Pro-IL-1β. In vitro, trans-Chalcone reduced the MSU-induced release of IL-1β in lipopolysaccharide (LPS)-primed macrophages. Therefore, the pharmacological effects of trans-Chalcone indicate its therapeutic potential as an analgesic and anti-inflammatory flavonoid for the treatment of gout." @default.
• W2891728466 created "2018-09-27" @default.
• W2891728466 creator A5006994441 @default.
• W2891728466 creator A5016912925 @default.
• W2891728466 creator A5017615120 @default.
• W2891728466 creator A5020393806 @default.
• W2891728466 creator A5031690868 @default.
• W2891728466 creator A5035877999 @default.
• W2891728466 creator A5064208545 @default.
• W2891728466 creator A5072583774 @default.
• W2891728466 creator A5074382470 @default.
• W2891728466 creator A5077513818 @default.
• W2891728466 creator A5078024039 @default.
• W2891728466 creator A5078701793 @default.
• W2891728466 creator A5085783926 @default.
• W2891728466 date "2018-10-02" @default.
• W2891728466 modified "2023-10-14" @default.
• W2891728466 title "Trans-Chalcone Attenuates Pain and Inflammation in Experimental Acute Gout Arthritis in Mice" @default.
• W2891728466 cites W1563578847 @default.
• W2891728466 cites W1897205387 @default.
• W2891728466 cites W1898174014 @default.
• W2891728466 cites W1971738884 @default.
• W2891728466 cites W1971915082 @default.
• W2891728466 cites W1972775390 @default.
• W2891728466 cites W1977479621 @default.
• W2891728466 cites W1978842100 @default.
• W2891728466 cites W1982727668 @default.
• W2891728466 cites W1984228225 @default.
• W2891728466 cites W1986696886 @default.
• W2891728466 cites W1991488724 @default.
• W2891728466 cites W1996872802 @default.
• W2891728466 cites W2007755013 @default.
• W2891728466 cites W2009800174 @default.
• W2891728466 cites W2016109284 @default.
• W2891728466 cites W2020930525 @default.
• W2891728466 cites W2025974944 @default.
• W2891728466 cites W2033029602 @default.
• W2891728466 cites W2046327214 @default.
• W2891728466 cites W2057039052 @default.
• W2891728466 cites W2060007746 @default.
• W2891728466 cites W2060389791 @default.
• W2891728466 cites W2061147690 @default.
• W2891728466 cites W2068079092 @default.
• W2891728466 cites W2095917499 @default.
• W2891728466 cites W2102354025 @default.
• W2891728466 cites W2104475738 @default.
• W2891728466 cites W2115158780 @default.
• W2891728466 cites W2115637834 @default.
• W2891728466 cites W2118904862 @default.
• W2891728466 cites W2122287804 @default.
• W2891728466 cites W2145938021 @default.
• W2891728466 cites W2149608846 @default.
• W2891728466 cites W2156607351 @default.
• W2891728466 cites W2157282220 @default.
• W2891728466 cites W2161982997 @default.
• W2891728466 cites W2165170037 @default.
• W2891728466 cites W2226523317 @default.
• W2891728466 cites W2258795479 @default.
• W2891728466 cites W2278476490 @default.
• W2891728466 cites W2284360474 @default.
• W2891728466 cites W2295140952 @default.
• W2891728466 cites W2298175511 @default.
• W2891728466 cites W2301131921 @default.
• W2891728466 cites W2480559039 @default.
• W2891728466 cites W2504800334 @default.
• W2891728466 cites W2528762545 @default.
• W2891728466 cites W2551668281 @default.
• W2891728466 cites W2585898138 @default.
• W2891728466 cites W2604030747 @default.
• W2891728466 cites W2611689827 @default.
• W2891728466 cites W2615130940 @default.
• W2891728466 cites W2619849522 @default.
• W2891728466 cites W2737497027 @default.
• W2891728466 cites W2769742086 @default.
• W2891728466 cites W2799784143 @default.
• W2891728466 cites W2807042775 @default.
• W2891728466 cites W4248403572 @default.
• W2891728466 cites W79914589 @default.
• W2891728466 doi "https://doi.org/10.3389/fphar.2018.01123" @default.
• W2891728466 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6176465" @default.
• W2891728466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30333752" @default.
• W2891728466 hasPublicationYear "2018" @default.
• W2891728466 type Work @default.
• W2891728466 sameAs 2891728466 @default.
• W2891728466 citedByCount "36" @default.
• W2891728466 countsByYear W28917284662019 @default.
• W2891728466 countsByYear W28917284662020 @default.
• W2891728466 countsByYear W28917284662021 @default.
• W2891728466 countsByYear W28917284662022 @default.
• W2891728466 countsByYear W28917284662023 @default.
• W2891728466 crossrefType "journal-article" @default.
• W2891728466 hasAuthorship W2891728466A5006994441 @default.
• W2891728466 hasAuthorship W2891728466A5016912925 @default.
• W2891728466 hasAuthorship W2891728466A5017615120 @default.
• W2891728466 hasAuthorship W2891728466A5020393806 @default.
• W2891728466 hasAuthorship W2891728466A5031690868 @default.
• W2891728466 hasAuthorship W2891728466A5035877999 @default.
• W2891728466 hasAuthorship W2891728466A5064208545 @default.
• W2891728466 hasAuthorship W2891728466A5072583774 @default.
• W2891728466 hasAuthorship W2891728466A5074382470 @default.

• next